Anastrazole and oral contraceptives: a novel treatment for endometriosis
article
OA: closed
CC0
⤵ 163 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper explores the combined use of anastrozole and oral contraceptives as a potential novel treatment for endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (15)
- Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target via openalex
- Aromatase expression in endometriosis via openalex
- Aromatase expression in endometriosis. via openalex
- Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis via openalex
- Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. via openalex
- Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up via openalex
- The evidence for the management of endometriosis via openalex
- Treatment of Severe Postmenopausal Endometriosis With an Aromatase Inhibitor via openalex
- W6656356435 via openalex
- W2128100826 via openalex
- W2151447010 via openalex
- W2159803441 via openalex
- W2313678972 via openalex
- W4236627566 via openalex
- W1932574503 via openalex
Cited by (50)
- Hormonal Dysregulation and Neuroinflammation in Endometriosis: Convergent Druggable Pathways 2026
- Letrozole plus metformin versus letrozole alone in the treatment of symptomatic endometrioma 2025
- Evaluating the Relative Efficacy of Synthetic and Natural Drugs in Endometriosis Adopting Molecular Modelling Approach 2024
- Additional file 1 of Injectable hydrogel nanoarchitectonics with near-infrared controlled drug delivery for in situ photothermal/endocrine synergistic endometriosis therapy 2024
- Additional file 1 of Injectable hydrogel nanoarchitectonics with near-infrared controlled drug delivery for in situ photothermal/endocrine synergistic endometriosis therapy 2024
- The long road of drug development for endometriosis - Pains, gains, and hopes 2024
- A Primer on Clinical Classification and Pathophysiology of Endometriosis 2024
- Targeting c-MYC: a potential non-hormonal therapeutic approach for endometriosis treatment 2023
- A novel anastrozole intravaginal ring for endometriosis: Pharmacokinetic characteristics and mucosal irritation 2023
- Injectable hydrogel nanoarchitectonics with near-infrared controlled drug delivery for in situ photothermal/endocrine synergistic endometriosis therapy 2023
- Low-dose letrozole - an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial 2023
- A Systematic Review of Systematic Reviews on the Use of Aromatase Inhibitors for the Treatment of Endometriosis: The Evidence to Date 2023
- Effectiveness of Norethisterone Acetate alone Versus in Combination with Letrozole for treatment of Chronic Pelvic Chronic Pain and Dyspareunia in Patients with Endometriosis 2022
- Hormonal Therapy in Endometriosis and Adenomyosis: Danazol, Aromatase Inhibitors 2022
- Advances in targeting estrogen synthesis and receptors in patients with endometriosis 2022
- Evaluation of the effect of aromatase inhibitor in reducing the size of endometrioma 2021
- Potential Therapeutic Options and Perspectives for Alleviation of Endometrial Estrogen Dominance and Progesterone Resistance in Endometriosis 2021
- Uso de inhibidores de la aromatasa en el tratamiento del dolor pélvico asociado a endometriosis: revisión sistemática 2021
- Additional file 1 of Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial 2021
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Molecular Mechanisms Underlying Adolescent Endometriosis and Advancements in Medical Management 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial. 2020
- Letrozole combined with oral contraceptives versus oral contraceptives alone in the treatment of endometriosis-related pain symptoms: a pilot study 2020
- Anastrozole and Levonorgrestrel-Releasing Intrauterine Device in the Treatment of Endometriosis: A Randomized Clinical Trial 2019
- Endometriosis 2019
- Endometriosis 2019
- Development of an intravaginal ring delivering simultaneously anastrozole and levonorgestrel: a pharmacokinetic perspective 2019
- Endometriosis 2019
- Endometriosis - Review Of Current Therapeutic Aproaches For Disease Control 2019
- Chapitre 3 : Prise en charge médicale de la douleur associée à l'endométriose 2019
- Novel Drug Targets with Traditional Herbal Medicines for Overcoming Endometriosis 2018
- Endometriosis and adenomyosis 2018
- Medical and Surgical Management of Endometriosis 2018
- Preparation and <i>in vitro/in vivo</i> evaluation of anastrozole reservoir‐type intravaginal ring 2018
- Current and emerging treatment options for endometriosis 2018
- Drug delivery for the treatment of endometriosis and uterine fibroids 2017
- The Root Aqueous Extract of <i>Entada africana</i> Guill. et Perr. (Mimosaceae) Inhibits Implant Growth, Alleviates Dysmenorrhea, and Restores Ovarian Dynamic in a Rat Model of Endometriosis 2017
- The role of oxidation-sensitive nociception and epigenetics in endometriosis-associated pain 2017
- Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal et perspectives thérapeutiques 2017
- Absence of Effect of Intravaginal Miconazole, Clindamycin, Nonoxynol‐9, and Tampons on the Pharmacokinetics of an Anastrozole/Levonorgestrel Intravaginal Ring 2017
- “Per vaginam” topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review 2017
- Lovastatin Reduces Stemness via Epigenetic Reprograming of <i>BMP2</i> and <i>GATA2</i> in Human Endometrium and Endometriosis. 2016
- Committee Opinion No. 663 2016
- Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial 2016
- Vitamin C is effective for the prevention and regression of endometriotic implants in an experimentally induced rat model of endometriosis 2016
- Drug therapy in the treatment of endometriosis 2016
- Model‐Based Dose Selection for Intravaginal Ring Formulations Releasing Anastrozole and Levonorgestrel Intended for the Treatment of Endometriosis Symptoms 2016
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:35.797702+00:00
License: CC0
· commercial use OK